Skip to main content

Table 1 Characteristics of Participants

From: Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: Part A - Medical results

 

Total

Phase 2 - treatment

Phase 2 - placebo

Total Participants

77

26

15

Male

69

24

14

Female

8

2

1

Age (years)

6.3

6.7

6.5

Diagnosis

95% autism, 3% PDD/NOS, 3% Asperger's

96% Autism, 4% Aspergers

100% Autism

Back to article page

BMC Clinical Pharmacology

ISSN: 1472-6904